Heartseed

IPO

Cardiac regeneration through iPSC cell therapy

Heartseed was founded in 2015, is headquartered in Tokyo, Japan, lists 11–50 employees, and has $77.6M in recorded funding across 3 rounds.

Headquarters
Tokyo
Employees
11–50
Founded
2015
Business Model
B2B
Total Funding
$77.6M
Last Round
$14.6M Series DMay 2023
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 6 investors for this company. The full record is or through the API.

About

Heartseed (Tokyo: 219A.T) is a Japanese biotechnology company focused on the research and development of iPSC (induced pluripotent stem cell)-based cardiac regeneration therapies for patients with severe heart failure. Founded in 2015 as a spinout from Keio University, the company develops cardiomyocyte spheroids that can supplement damaged heart muscle tissue. Heartseed completed an IPO on the Tokyo Stock Exchange on July 30, 2024, having raised over $84 million across seven funding rounds, with investors including SMBC Venture Capital and Keio Innovation Initiative.

Summary

Heartseed is a Biotech company based in Tokyo, Japan, founded in 2015. It lists 11–50 employees. It has raised $77.6M in total across 3 rounds, most recently a $14.6M Series D round in May 2023. Investors include SMBC Venture Capital, Astellas Venture Management and UTokyo Innovation Platform.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOJul 2024
$10.1M

Sign up to see all 4 events

Funding: Series B through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Heartseed on Indexed.vc
<a href="https://indexed.vc/companies/heartseed"><img src="https://indexed.vc/api/badge/company/heartseed" alt="Heartseed on Indexed.vc" width="260" height="76" /></a>